# Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women

> **NCT06997653** · PHASE2 · WITHDRAWN · sponsor: **Health Institutes of Turkey**

## Conditions studied

- COVID-19
- SARS CoV 2 Infection

## Interventions

- **BIOLOGICAL:** TURKOVAC

## Key facts

- **NCT ID:** NCT06997653
- **Lead sponsor:** Health Institutes of Turkey
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** the clinical trial did not initiated
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06997653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06997653, "Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06997653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*